Financhill
Buy
65

ABT Quote, Financials, Valuation and Earnings

Last price:
$126.70
Seasonality move :
3.81%
Day range:
$124.50 - $128.49
52-week range:
$99.71 - $141.23
Dividend yield:
1.77%
P/E ratio:
16.56x
P/S ratio:
5.28x
P/B ratio:
4.61x
Volume:
9.5M
Avg. volume:
6.7M
1-year change:
6.61%
Market cap:
$219.8B
Revenue:
$42B
EPS (TTM):
$7.65

Earnings Data

Next earnings date for ABT
Apr 17
2025
Most recent earnings per share
$5.27
Beat by $3.93
(Jan 22/2025)
Consensus Estimate
$1.34
(Jan 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ABT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/17/2025 Q1 $10.4B -- -- $1.06 --
01/22/2025 Q4 $11B $11B $5.27 $1.34 $3.93
10/16/2024 Q3 $10.6B $10.6B $0.94 $1.20 -$0.26
07/18/2024 Q2 $10.4B $10.4B $0.74 $1.10 -$0.36
04/17/2024 Q1 $9.9B $10B $0.70 $0.95 -$0.25
01/24/2024 Q4 $10.2B $10.2B $0.91 $1.19 -$0.28
10/18/2023 Q3 -- -- $0.82 $1.10 -$0.28
07/20/2023 Q2 -- -- $0.78 $1.05 -$0.27
04/19/2023 Q1 -- -- $0.75 $0.99 -$0.24
01/25/2023 Q4 -- -- $0.59 $0.94 -$0.35
10/19/2022 Q3 -- -- $0.81 $0.94 -$0.13
07/20/2022 Q2 -- -- $1.14 $1.14 -$0.00
04/20/2022 Q1 -- -- $1.37 $1.46 -$0.09
01/26/2022 Q4 -- -- $1.11 $1.21 -$0.10
10/20/2021 Q3 -- -- $1.17 $0.95 $0.22
07/22/2021 Q2 -- -- $0.66 $1.02 -$0.36
04/20/2021 Q1 -- -- $1.00 $1.27 -$0.27
01/27/2021 Q4 -- -- $1.20 -- --
10/21/2020 Q3 -- -- $0.69 -- --
07/16/2020 Q2 -- -- $0.30 -- --
04/16/2020 Q1 -- -- $0.31 -- --
01/22/2020 Q4 -- -- $0.59 -- --
10/16/2019 Q3 -- -- $0.53 -- --
07/17/2019 Q2 -- -- $0.56 -- --
04/17/2019 Q1 -- -- $0.38 -- --
01/23/2019 Q4 -- -- $0.37 -- --
10/17/2018 Q3 -- -- $0.32 -- --
07/18/2018 Q2 -- -- $0.41 -- --
04/18/2018 Q1 -- -- $0.23 -- --
01/24/2018 Q4 -- -- -$0.48 -- --
10/18/2017 Q3 -- -- $0.34 -- --
07/20/2017 Q2 -- -- $0.16 -- --
04/19/2017 Q1 -- -- $0.24 -- --
01/25/2017 Q4 -- -- $0.53 -- --
10/19/2016 Q3 -- -- -$0.22 -- --
07/20/2016 Q2 -- -- $0.41 -- --
04/20/2016 Q1 -- -- $0.21 -- --
01/28/2016 Q4 -- -- $0.51 -- --
10/21/2015 Q3 -- -- $0.38 -- --
07/22/2015 Q2 -- -- $0.52 -- --
04/22/2015 Q1 -- -- $1.51 -- --

Abbott Laboratories Earnings Questions

  • How Much did Abbott Laboratories Generate in Revenue Last Quarter?

    Abbott Laboratories reported $11B worth of top line sales in its most recent quarter.

  • Did Abbott Laboratories Beat Earnings Last Quarter?

    Abbott Laboratories announced earnings per share of $5.27 which represents a beat of analyst forecast a $1.34 per share.

  • Is Abbott Laboratories Profitable?

    Abbott Laboratories reported $6B that represents $3.46 per share over the last quarter.

  • What is the Analyst Consensus for Abbott Laboratories EPS Next Year?

    Abbott Laboratories's earnings are forecast to decrease from $7.64 per share to $5.15 per share next year representing a decrease of -32.58%.

  • When is Abbott Laboratories's Earnings Date?

    Abbott Laboratories's next earnings date is April 17, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock